Go Pro
NYSE:AVNS

Avanos Medical Q1 2026 Earnings Report

Avanos Medical logo
$24.99 0.00 (0.00%)
As of 09/18/2026

Avanos Medical EPS Results

Actual EPS
$0.22
Consensus EPS
$0.16
Beat/Miss
Beat by +$0.06
One Year Ago EPS
$0.26

Avanos Medical Revenue Results

Actual Revenue
$182.20 million
Expected Revenue
$170.00 million
Beat/Miss
Beat by +$12.20 million
YoY Revenue Growth
+8.80%

Avanos Medical Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
Tuesday, May 5, 2026
Conference Call Time
4:00PM ET

Avanos Medical Earnings Headlines

Why This Small AI Company Holds 150 Patents
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI company holding 150 patents for technology that processes information up to 1,000 times faster than standard AI. Wall Street projects the company's sales to more than triple in the coming year, and Brown notes it's roughly the same size Nvidia was a decade ago, with a key catalyst set for November 11.tc pixel
See More Avanos Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avanos Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your email.

About Avanos Medical

Avanos Medical (NYSE:AVNS) (NYSE: AVNS) is a medical technology company that develops and markets devices designed to improve patient care and support healthcare providers. Its products are used in areas including pain management, digestive health, and other procedural and specialty-care applications.

The company’s portfolio includes the COOLIEF radiofrequency ablation system and ON-Q pain relief systems for non-opioid pain management, as well as MIC-KEY feeding tubes and the CORTRAK* 2 Enteral Access System for enteral nutrition and feeding-tube placement. Avanos sells its products to hospitals, healthcare professionals, and other care settings.

Avanos was formed following the 2014 separation of Halyard Health from Kimberly-Clark and adopted the Avanos name in 2018. Based in Alpharetta, Georgia, the company serves healthcare markets internationally through a commercial presence spanning multiple geographic regions.

View Avanos Medical Profile